<DOC>
	<DOCNO>NCT02234063</DOCNO>
	<brief_summary>In genomic medicine implementation pilot project , investigator aim conduct randomize trial network community health center primary care facility study process , effect challenge incorporate information apolipoprotein L1 ( APOL1 ) -attributable genetic risk end stage kidney disease patient African ancestry hypertension .</brief_summary>
	<brief_title>Genetic Testing Understand Address Renal Disease Disparities</brief_title>
	<detailed_description>CKD commonly associate diabetes ( 40 % ) hypertension ( 28 % ) , affect 26 million American adult . African ancestry population hypertension ( HTN ) 2- 3-fold high risk develop CKD , 5-fold increase risk progress end stage renal disease ( ESRD ) compare white . HTN risk factor progression CKD increase cardiovascular risk CKD . Thus target blood pressure control modifiable risk factor may reduce CVD people CKD reduce progression CKD end stage disease . Recent discovery demonstrate testable allele APOL1 locus chromosome 22 major effect explain almost excess risk hypertension-associated CKD progression ESRD African ancestry population . We use community-engaged approach enroll patient African Ancestry HTN network community health center primary care facility Harlem Bronx randomize 7 1 ratio receive APOL1 genetic test EMR-enabled provider clinical decision support incorporate APOL1 genomic risk information .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Ages1865 Selfidentifies Black/African American History hypertension Patient participate site History Chronic Kidney Disease History Diabetes Pregnant Cognitively impaired/unable provide consent Terminally ill Planning leave area study permanently one year study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>End Stage Renal Disease</keyword>
	<keyword>APOL1</keyword>
	<keyword>Genomics</keyword>
	<keyword>Genetics</keyword>
	<keyword>Community-engaged</keyword>
</DOC>